Regulus Therapeutics reported $8K in Trade Debtors for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Debtors Change
Alnylam Pharmaceuticals ALNY:US $ 156.53M 42.04M
AstraZeneca AZN:LN 9.05B 1.26B
Astrazeneca AZN:US 9.05B 1.26B
Biogen BIIB:US $ 2021.4M 59.7M
Celldex Therapeutics CLDX:US $ 0.24M 0.07M
Gilead Sciences GILD:US $ 3787M 706M
GlaxoSmithKline GSK:LN 8.8B 451M
Intercept Pharmaceuticals ICPT:US $ 46.14M 1.47M
Intrexon XON:US $ 24.87M 3.4M
Lexicon Pharmaceuticals LXRX:US 37K 23K
Ligand Pharmaceuticals LGND:US $ 41.8M 49.85M
Merk MRK:US $ 9828M 598M
Omeros OMER:US $ 60.36M 22.11M
Regulus Therapeutics RGLS:US $ 0.01M 0.01M
Sangamo Biosciences SGMO:US $ 7.29M 0.93M
Spectrum Pharmaceuticals SPPI:US $ 0.64M 0.39M
Takeda 4502:JP Y 724377M 31740M
Vital Therapies VTL:US $ 0.58M 0.31M
YTE INCY:US $ 562.34M 53.96M